{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:41:35Z","timestamp":1758055295172,"version":"3.44.0"},"reference-count":35,"publisher":"Bentham Science Publishers Ltd.","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62171298","82071876"],"award-info":[{"award-number":["62171298","82071876"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016126","name":"Beijing Hospitals Authority Clinical Medicine Development of Special Funding","doi-asserted-by":"publisher","award":["ZYLX202101"],"award-info":[{"award-number":["ZYLX202101"]}],"id":[{"id":"10.13039\/100016126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2021ZD0113200"],"award-info":[{"award-number":["2021ZD0113200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMIR"],"published-print":{"date-parts":[[2025,9,3]]},"abstract":"<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>This study aimed to assess the effectiveness and precision of a deep learning-based model in forecasting the early response of HCC patients to\nTACE.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A comprehensive review of HCC-TACE data involving 111 patients with HCC was carried out, encompassing both pre-TACE MR images\n(captured before the first TACE) and post-TACE imaging (acquired between 30 and 60 days following TACE). Based on the mRECIST criteria,\npatients were divided into two cohorts: a training dataset (91 subjects, 645 images) and a test dataset (20 subjects, 155 images). A deep learningbased\nmodel utilizing LeNet architecture with an attention mechanism was developed, targeting the prediction of HCC patients' response to TACE.\nThe robustness and accuracy of the model were examined via ROC curves and confusion matrices.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Post-TACE treatment, 56 patients (50.5%) manifested an objective response (CR+PR), whereas 55 patients (49.5%) exhibited no response\n(SD+PD). Concerning the model's predictive ability for TACE response, the AUC was found to be 0.760 in the training dataset and 0.729 in the\ntest dataset. The model's prediction accuracy was further corroborated by the confusion matrix, revealing an average accuracy of 70.7% in the\ntraining dataset and 72.3% in the test dataset.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Implementing a deep learning-based model using MRI data is potent for forecasting HCC patients\u2019 response to TACE treatment. The novel LeNet\nmodel with the attention mechanism conceived in this study contributes valuable insights that can guide the formulation of effective treatment\nstrategies.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115734056367143250610045305","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T02:07:55Z","timestamp":1750990075000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting Treatment Response to Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients using a Deep Learning-based Approach"],"prefix":"10.2174","volume":"21","author":[{"given":"Zhi-Wei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Radiology, Beijing Friendship Hospital, Capital Medical University, 95 YongAn Road, Xicheng District, Beijing, 100050, P.R. China | Department of Radiology, Beijing Jianjia Rehabilitation Hospital, Building 3, Yard 6, Kangxin Road, Fengtai District, Beijing, 100071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wang","family":"Yuan","sequence":"additional","affiliation":[{"name":"Center of Interventional Oncology and Liver Diseases, Beijing Youan Hospital, Capital Medical University; No.8 Xitoutiao, Youwai St, Fengtai District, Beijing, 100069, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiography, Beijing Friendship Hospital, Capital Medical University, 95 YongAn Road, Xicheng District, Beijing, 100050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Friendship Hospital, Capital Medical University, 95 YongAn Road, Xicheng District, Beijing, 100050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Friendship Hospital, Capital Medical University, 95 YongAn Road, Xicheng District, Beijing, 100050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ma","sequence":"additional","affiliation":[{"name":"Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Chang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Friendship Hospital, Capital Medical University, 95 YongAn Road, Xicheng District, Beijing, 100050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Han","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Friendship Hospital, Capital Medical University, 95 YongAn Road, Xicheng District, Beijing, 100050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3189-8354","authenticated-orcid":true,"given":"A-Hong","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Friendship Hospital, Capital Medical University, 95 YongAn Road, Xicheng District, Beijing, 100050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"Marrero J.A.","year":"2018","unstructured":"Marrero J.A.; Kulik L.M.; Sirlin C.B.; Zhu A.X.; Finn R.S.; Abecassis M.M.; Roberts L.R.; Heimbach J.K.; Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the american association for the study of liver diseases. Hepatology  2018,68(2),723-750","journal-title":"Hepatology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11684-014-0331-5","volume":"8","author":"Yu R.","year":"2014","unstructured":"Yu R.; Fan R.; Hou J.; Chronic hepatitis B virus infection: Epidemiology, prevention, and treatment in China. Front Med  2014,8(2),135-144","journal-title":"Front Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s12094-017-1621-6","volume":"19","author":"Xiang X.","year":"2017","unstructured":"Xiang X.; Zhong J.H.; Wang Y.Y.; You X.M.; Ma L.; Xiang B.D.; Li L.Q.; Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma. Clin Transl Oncol  2017,19(7),891-897","journal-title":"Clin Transl Oncol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/JHC.S462168","volume":"11","author":"Li Y.K.","year":"2024","unstructured":"Li Y.K.; Wu S.; Wu Y.S.; Zhang W.H.; Wang Y.; Li Y.H.; Kang Q.; Huang S.Q.; Zheng K.; Jiang G.M.; Wang Q.B.; Liang Y.B.; Li J.; Lakang Y.; Yang C.; Li J.; Wang J.P.; Kui X.; Ke Y.; Portal venous and hepatic arterial coefficients predict post-hepatectomy overall and recurrence-free survival in patients with hepatocellular carcinoma: A retrospective study. J Hepatocell Carcinoma  2024,11,1389-1402","journal-title":"J Hepatocell Carcinoma"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"Galle P.R.","year":"2018","unstructured":"Galle P.R.; Forner A.; Llovet J.M.; Mazzaferro V.; Piscaglia F.; Raoul J-L.; Schirmacher P.; Vilgrain V.; Management of hepatocellular carcinoma. J Hepatol  2018,69(1),182-236","journal-title":"J Hepatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4292\/wjgpt.v7.i4.477","volume":"7","author":"Facciorusso A.","year":"2016","unstructured":"Facciorusso A.; Serviddio G.; Muscatiello N.; Local ablative treatments for hepatocellular carcinoma: An updated review. World J Gastrointest Pharmacol Ther  2016,7(4),477-489","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/jjco\/hyy138","volume":"48","author":"Jin P.P.","year":"2018","unstructured":"Jin P.P.; Shao S.Y.; Wu W.T.; Zhao X.Y.; Huang B.F.; Fu Q.H.; Que R.S.; Hu Q.D.; Combination of transarterial chemoembolization and sorafenib improves outcomes of unresectable hepatocellular carcinoma: An updated systematic review and meta-analysis. Jpn J Clin Oncol  2018,48(12),1058-1069","journal-title":"Jpn J Clin Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jmri.26977","volume":"52","author":"Song W.","year":"2020","unstructured":"Song W.; Yu X.; Guo D.; Liu H.; Tang Z.; Liu X.; Zhou J.; Zhang H.; Liu Y.; Liu X.; MRI-based radiomics: Associations with the recurrence-free survival of patients with hepatocellular carcinoma treated with conventional transcatheter arterial chemoembolization. J Magn Reson Imaging  2020,52(2),461-473","journal-title":"J Magn Reson Imaging"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1055\/s-0032-1329906","volume":"32","author":"Bolondi L.","year":"2013","unstructured":"Bolondi L.; Burroughs A.; Dufour J-F.; Galle P.; Mazzaferro V.; Piscaglia F.; Raoul J.; Sangro B.; Bolondi L.; Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: Proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis  2013,32(4),348-359","journal-title":"Semin Liver Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1111\/liv.12844","volume":"35","author":"Sciarra A.","year":"2015","unstructured":"Sciarra A.; Ronot M.; Di Tommaso L.; Raschioni C.; Castera L.; Belghiti J.; Bedossa P.; Vilgrain V.; Roncalli M.; Paradis V.; TRIP: A pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma. Liver Int  2015,35(11),2466-2473","journal-title":"Liver Int"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12880-022-00900-8","volume":"22","author":"Li Z.W.","year":"2022","unstructured":"Li Z.W.; Ren A.H.; Yang D.W.; Xu H.; Wei J.; Yuan C.W.; Wang Z.C.; Yang Z.H.; Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features. BMC Med Imaging  2022,22(1),176","journal-title":"BMC Med Imaging"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1007\/s00330-015-3982-y","volume":"26","author":"Vesselle G.","year":"2016","unstructured":"Vesselle G.; Quirier-Leleu C.; Velasco S.; Charier F.; Silvain C.; Boucebci S.; Ingrand P.; Tasu J.P.; Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma. Eur Radiol  2016,26(6),1640-1648","journal-title":"Eur Radiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"20190073","DOI":"10.1259\/bjr.20190073","volume":"92","author":"Zhang H.","year":"2019","unstructured":"Zhang H.; He X.; Yu J.; Song W.; Liu X.; Liu Y.; Zhou J.; Guo D.; Preoperative MRI features and clinical laboratory indicators for predicting the early therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization combined with High-intensity focused ultrasound treatment. Br J Radiol  2019,92(1099),20190073","journal-title":"Br J Radiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/hepr.12912","volume":"48","author":"Hatanaka T.","year":"2018","unstructured":"Hatanaka T.; Arai H.; Shibasaki M.; Tojima H.; Takizawa D.; Toyoda M.; Takayama H.; Abe T.; Sato K.; Kakizaki S.; Yamada M.; Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon-occluded transcatheter arterial chemoembolization: A retrospective cohort study. Hepatol Res  2018,48(2),165-175","journal-title":"Hepatol Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1148\/radiol.13130591","volume":"270","author":"Vandecaveye V.","year":"2014","unstructured":"Vandecaveye V.; Michielsen K.; De Keyzer F.; Laleman W.; Komuta M.; Op de beeck K.; Roskams T.; Nevens F.; Verslype C.; Maleux G.; Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome. Radiology  2014,270(3),747-757","journal-title":"Radiology"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.7150\/jca.32491","volume":"11","author":"Yuan Z.G.","year":"2020","unstructured":"Yuan Z.G.; Wang Z.Y.; Xia M.Y.; Li F.Z.; Li Y.; Shen Z.; Wang X.Z.; Diffusion kurtosis imaging for assessing the therapeutic response of transcatheter arterial chemoembolization in hepatocellular carcinoma. J Cancer  2020,11(8),2339-2347","journal-title":"J Cancer"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/jmri.25617","volume":"46","author":"Wu L.","year":"2017","unstructured":"Wu L.; Xu P.; Rao S.; Yang L.; Chen C.; Liu H.; Fu C.; Zeng M.; ADC  ratio and D ratio derived from intravoxel incoherent motion early after TACE are independent predictors for survival in hepatocellular carcinoma. J Magn Reson Imaging  2017,46(3),820-830","journal-title":"J Magn Reson Imaging"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1007\/s00330-020-06931-5","volume":"30","author":"Schobert I.T.","year":"2020","unstructured":"Schobert I.T.; Savic L.J.; Chapiro J.; Bousabarah K.; Chen E.; Laage-Gaupp F.; Tefera J.; Nezami N.; Lin M.; Pollak J.; Schlachter T.; Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. Eur Radiol  2020,30(10),5663-5673","journal-title":"Eur Radiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2217\/fon-2018-0591","volume":"15","author":"Wang B.","year":"2019","unstructured":"Wang B.; Li F.; Cheng L.; Zhan Y.; Wu B.; Chen P.; Shen J.; Wu W.; Ma X.; Zhu J.; Pan B.; Guo W.; Cheng Y.; The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma. Future Oncol  2019,15(8),827-839","journal-title":"Future Oncol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/jmri.27143","volume":"52","author":"Sun Y.","year":"2020","unstructured":"Sun Y.; Bai H.; Xia W.; Wang D.; Zhou B.; Zhao X.; Yang G.; Xu L.; Zhang W.; Liu P.; Xu J.; Meng S.; Liu R.; Gao X.; Predicting the outcome of transcatheter arterial embolization therapy for unresectable hepatocellular carcinoma based on radiomics of preoperative multiparameter MRI. J Magn Reson Imaging  2020,52(4),1083-1090","journal-title":"J Magn Reson Imaging"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00330-019-06318-1","volume":"30","author":"Peng J.","year":"2020","unstructured":"Peng J.; Kang S.; Ning Z.; Deng H.; Shen J.; Xu Y.; Zhang J.; Zhao W.; Li X.; Gong W.; Huang J.; Liu L.; Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging. Eur Radiol  2020,30(1),413-424","journal-title":"Eur Radiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"730282","DOI":"10.3389\/fonc.2021.730282","volume":"11","author":"Peng J.","year":"2021","unstructured":"Peng J.; Huang J.; Huang G.; Zhang J.; Predicting the initial treatment response to transarterial chemoembolization in intermediate-stage hepatocellular carcinoma by the integration of radiomics and deep learning. Front Oncol  2021,11,730282","journal-title":"Front Oncol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1007\/s00330-021-07803-2","volume":"31","author":"Kim D.W.","year":"2021","unstructured":"Kim D.W.; Lee G.; Kim S.Y.; Ahn G.; Lee J.G.; Lee S.S.; Kim K.W.; Park S.H.; Lee Y.J.; Kim N.; Deep learning\u2013based algorithm to detect primary hepatic malignancy in multiphase CT of patients at high risk for HCC. Eur Radiol  2021,31(9),7047-7057","journal-title":"Eur Radiol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jmri.27538","volume":"54","author":"Zhang Y.","year":"2021","unstructured":"Zhang Y.; Lv X.; Qiu J.; Zhang B.; Zhang L.; Fang J.; Li M.; Chen L.; Wang F.; Liu S.; Zhang S.; Deep learning with  convolutional neural network for noninvasive prediction of microvascular invasion in hepatocellular carcinoma. J Magn Reson Imaging  2021,54(1),134-143","journal-title":"J Magn Reson Imaging"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1109\/TCBB.2021.3079216","volume":"19","author":"Jia X","year":"2022","unstructured":"Jia X; Sun Z; Mi Q; Yang Z; Yang D.; A multimodality-contribution-aware tripnet for histologic grading of hepatocellular carcinoma. IEEE\/ACM Trans Comput Biol Bioinform  2022,19(4),2003-2016","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"593292","DOI":"10.3389\/fonc.2020.593292","volume":"10","author":"Zhang L.","year":"2020","unstructured":"Zhang L.; Xia W.; Yan Z.P.; Sun J.H.; Zhong B.Y.; Hou Z.H.; Yang M.J.; Zhou G.H.; Wang W.S.; Zhao X.Y.; Jian J.M.; Huang P.; Zhang R.; Zhang S.; Zhang J.Y.; Li Z.; Zhu X.L.; Gao X.; Ni C.F.; Deep learning predicts overall survival of patients with unresectable hepatocellular carcinoma treated by transarterial chemoembolization plus sorafenib. Front Oncol  2020,10,593292","journal-title":"Front Oncol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3760\/cma.j.cn112152-20240605-00240","volume":"46","author":"Li Y.K.","year":"2024","unstructured":"Li Y.K.; Wang Q.B.; Liang Y.B.; Ke Y.; CT measurement of blood perfusion in hepatocellular carcinoma: From basic principle, measurement methods to clinical application. Zhonghua Zhong Liu Za Zhi  2024,46(10),940-947","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"Lencioni R.","year":"2010","unstructured":"Lencioni R.; Llovet J.; Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis  2010,30(1),52-60","journal-title":"Semin Liver Dis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e180021","DOI":"10.1148\/ryai.2019180021","volume":"1","author":"Morshid A.","year":"2019","unstructured":"Morshid A.; Elsayes K.M.; Khalaf A.M.; Elmohr M.M.; Yu J.; Kaseb A.O.; Hassan M.; Mahvash A.; Wang Z.; Hazle J.D.; Fuentes D.; A machine learning model to predict hepatocellular carcinoma response to transcatheter arterial chemoembolization. Radiol Artif Intell  2019,1(5),e180021","journal-title":"Radiol Artif Intell"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1007\/s00330-021-07910-0","volume":"31","author":"Kong C.","year":"2021","unstructured":"Kong C.; Zhao Z.; Chen W.; Lv X.; Shu G.; Ye M.; Song J.; Ying X.; Weng Q.; Weng W.; Fang S.; Chen M.; Tu J.; Ji J.; Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE. Eur Radiol  2021,31(10),7500-7511","journal-title":"Eur Radiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1148\/radiol.2017170706","volume":"286","author":"Yasaka K.","year":"2018","unstructured":"Yasaka K.; Akai H.; Abe O.; Kiryu S.; Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: A preliminary study. Radiology  2018,286(3),887-896","journal-title":"Radiology"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jvir.2018.01.769","volume":"29","author":"Abajian A.","year":"2018","unstructured":"Abajian A.; Murali N.; Savic L.J.; Laage-Gaupp F.M.; Nezami N.; Duncan J.S.; Schlachter T.; Lin M.; Geschwind J.F.; Chapiro J.; Predicting treatment response to intra-arterial therapies for hepatocellular carcinoma with the use of supervised machine learning\u2014an artificial intelligence concept. J Vasc Interv Radiol  2018,29(6),850-857.e1","journal-title":"J Vasc Interv Radiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s00330-019-06553-6","volume":"30","author":"Liu D.","year":"2020","unstructured":"Liu D.; Liu F.; Xie X.; Su L.; Liu M.; Xie X.; Kuang M.; Huang G.; Wang Y.; Zhou H.; Wang K.; Lin M.; Tian J.; Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound. Eur Radiol  2020,30(4),2365-2376","journal-title":"Eur Radiol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1109\/5.726791","volume":"86","author":"Lecun Y.","year":"1998","unstructured":"Lecun Y.; Bottou L.; Gradient-based learning applied to document recognition. Proc IEEE Inst Electr Electron Eng  1998,86(11),2278-2324","journal-title":"Proc IEEE Inst Electr Electron Eng"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1109\/CVPR.2018.00745","author":"Hu J.","unstructured":"Hu J.; Shen L.; Sun G.; Squeeze-and-excitation networks. 2018 IEEE\/CVF Conference on Computer Vision and Pattern Recognition (CVPR)  Salt Lake City, UT, USA, 18-23 June 2018, pp. 7132-7141.","journal-title":"2018 IEEE\/CVF Conference on Computer Vision and Pattern Recognition (CVPR)"}],"container-title":["Current Medical Imaging Formerly Current Medical Imaging Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/242869","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/242869\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/242869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:04:35Z","timestamp":1757923475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/242869\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":35,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734056367143250610045305","relation":{},"ISSN":["1573-4056"],"issn-type":[{"type":"print","value":"1573-4056"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15734056367143"}}